Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Nu Holdings
NU
|
$652M |
| 2 |
Symbotic
SYM
|
$427M |
| 3 |
Coupang
CPNG
|
$411M |
| 4 |
Meta Platforms (Facebook)
META
|
$363M |
| 5 |
Mobileye
MBLY
|
$243M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$3.14B |
| 2 |
Spotify
SPOT
|
$579M |
| 3 |
Broadridge
BR
|
$577M |
| 4 |
Mercado Libre
MELI
|
$524M |
| 5 |
Charles Schwab
SCHW
|
$501M |
Sector Composition
| 1 | Technology | 28.97% |
| 2 | Consumer Discretionary | 27.33% |
| 3 | Communication Services | 14.17% |
| 4 | Healthcare | 14.03% |
| 5 | Financials | 5.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Wabtec
WAB
$32.8B
| $26.5M | 0.02% |
181,975
-11,539
| -6% | -$1.68M |
|
|
EXAI
177
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $26.2M | 0.02% |
4,574,405
-116,075
| -2% | -$664K |
|
178
Ambarella
AMBA
$3.54B
| $25.5M | 0.02% |
502,879
-15,401
| -3% | -$782K |
|
179
Mine Safety
MSA
$6.67B
| $25.2M | 0.02% |
130,082
+52,335
| +67% | +$10.1M |
|
|
ADAP
180
Adaptimmune Therapeutics
ADAP
$13.5M
| $25.1M | 0.02% |
15,871,875
-40,265
| -0.3% | -$63.6K |
|
181
Beam Therapeutics
BEAM
$2.04B
| $24.9M | 0.02% |
752,394
-11,729
| -2% | -$388K |
|
182
Ares Capital
ARCC
$15.8B
| $24.6M | 0.02% |
1,183,649
+179,770
| +18% | +$3.74M |
|
183
Veeco
VECO
$1.46B
| $24.5M | 0.02% |
695,446
-42,014
| -6% | -$1.48M |
|
184
dLocal
DLO
$3.78B
| $22.7M | 0.02% |
1,546,091
+552,104
| +56% | +$8.12M |
|
185
Transmedics
TMDX
$3.49B
| $22.4M | 0.02% |
303,162
-5,816
| -2% | -$430K |
|
186
Clear Secure
YOU
$3.34B
| $21.3M | 0.02% |
1,000,000
| – | – |
|
187
Burford Capital
BUR
$2.92B
| $20.8M | 0.02% |
1,327,511
+703,518
| +113% | +$11M |
|
188
KE Holdings
BEKE
$22.3B
| $20.1M | 0.02% |
1,463,628
-90,735
| -6% | -$1.25M |
|
189
Digimarc
DMRC
$179M
| $19.6M | 0.02% |
720,827
-1,432
| -0.2% | -$38.9K |
|
190
Chegg
CHGG
$178M
| $19.5M | 0.02% |
2,579,090
-2,103,297
| -45% | -$15.9M |
|
191
Trupanion
TRUP
$1.9B
| $19.2M | 0.02% |
696,250
-1,119
| -0.2% | -$30.9K |
|
192
Brookfield Renewable
BEPC
$5.94B
| $19.1M | 0.01% |
778,630
+135,765
| +21% | +$3.34M |
|
193
Charles River Laboratories
CRL
$8.06B
| $18.3M | 0.01% |
67,534
-2,668
| -4% | -$723K |
|
|
NBTX
194
Nanobiotix
NBTX
$407M
| $17.9M | 0.01% |
2,869,030
| – | – |
|
195
Waters Corp
WAT
$18.2B
| $17.4M | 0.01% |
50,634
-4,472
| -8% | -$1.54M |
|
196
Carlisle Companies
CSL
$16.9B
| $17.3M | 0.01% |
+44,095
| New | +$17.3M |
|
197
Estee Lauder
EL
$32.2B
| $17.1M | 0.01% |
111,159
-1,583,436
| -93% | -$244M |
|
198
Brookfield
BN
$98.5B
| $17M | 0.01% |
404,949
+162,453
| +67% | +$6.8M |
|
199
QuantumScape
QS
$4.42B
| $16.9M | 0.01% |
2,679,518
+251,186
| +10% | +$1.58M |
|
200
Progressive
PGR
$144B
| $15.9M | 0.01% |
77,056
-3,689
| -5% | -$763K |
|